Literature DB >> 1731113

Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex.

Y P Xia1, C T Yeh, J H Ou, M M Lai.   

Abstract

Hepatitis delta antigen (HDAg) is the only protein encoded by hepatitis delta virus (HDV). HDAg has been demonstrated in the nuclei of HDV-infected hepatocytes, and its nuclear transport may be important for the replication of HDV RNA. In this report, we investigated the mechanism of nuclear transport of HDAg. By expressing fusion proteins consisting of the different portions of HDAg and alpha-globin, we have identified a nuclear localization signal (NLS) within the N-terminal one-third of HDAg. It consists of two stretches of basic amino acid domains separated by a short run of nonbasic amino acids. Both of the basic domains are necessary for the efficient nuclear transport of HDAg. The nonbasic spacer amino acids could be removed without affecting the nuclear targeting of HDAg significantly. Thus, the HDAg NLS belongs to a newly identified class of NLS which consists of two discontiguous stretches of basic amino acids. This NLS is separated from a stretch of steroid receptor NLS-like sequence, which is also present but not functioning as an NLS, in HDAg. Furthermore, we have shown that subfragments of HDAg which do not contain the NLS can be passively transported into the nucleus by a trans-acting full-length HDAg, provided that these subfragments contain the region with a leucine zipper sequence. Thus, our results indicate that HDAg forms aggregates in the cytoplasm and that the HDAg oligomerization is probably mediated by the leucine zipper sequence. Therefore, HDAg is likely transported into the nucleus as a protein complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731113      PMCID: PMC240792     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The hepatitis delta (delta) virus possesses a circular RNA.

Authors:  A Kos; R Dijkema; A C Arnberg; P H van der Meide; H Schellekens
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

2.  Type D (delta) hepatitis.

Authors:  J H Hoofnagle
Journal:  JAMA       Date:  1989-03-03       Impact factor: 56.272

3.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

4.  Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA.

Authors:  J H Lin; M F Chang; S C Baker; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

6.  Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line.

Authors:  T B Macnaughton; E J Gowans; A R Jilbert; C J Burrell
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

7.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

8.  Epidemiology and clinical impact of hepatitis D virus (delta) infection.

Authors:  I M Jacobson; J L Dienstag; B G Werner; D B Brettler; P H Levine; I K Mushahwar
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

9.  Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.

Authors:  M F Chang; S C Baker; L H Soe; T Kamahora; J G Keck; S Makino; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Nuclear transport of adenovirus DNA polymerase is facilitated by interaction with preterminal protein.

Authors:  L J Zhao; R Padmanabhan
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

View more
  45 in total

1.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen.

Authors:  Chun-Chung Wang; Tsung-Cheng Chang; Ching-Wen Lin; Hsiu-Ling Tsui; Page B C Chu; Bo-Shun Chen; Zhi-Shun Huang; Huey-Nan Wu
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

4.  Baculovirus transregulator IE1 requires a dimeric nuclear localization element for nuclear import and promoter activation.

Authors:  Victoria A Olson; Justin A Wetter; Paul D Friesen
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

8.  Determination of the multimerization state of the hepatitis delta virus antigens in vivo.

Authors:  Cromwell T Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigen.

Authors:  J W Cheng; I J Lin; Y C Lou; M T Pai; H N Wu
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

10.  Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins.

Authors:  N Ishii; A Nakanishi; M Yamada; M H Macalalad; H Kasamatsu
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.